Page last updated: 2024-10-23

bisbenzimidazole and Leukoplakia, Oral

bisbenzimidazole has been researched along with Leukoplakia, Oral in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Leukoplakia, Oral: A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizuki, H1

Other Studies

1 other study available for bisbenzimidazole and Leukoplakia, Oral

ArticleYear
In situ staining with DNA-binding fluorescent dye, Hoechst 33258, to detect microorganisms in the epithelial cells of oral leukoplakia.
    Oral oncology, 2001, Volume: 37, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bisbenzimidazole; Case-Control Studies; Child; Cytoplasm

2001